(en) Meyer PR, Rutvisuttinunt W, Matsuura SE, So AG, Scott WA, « Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet », J Mol Biol., vol. 369, no 1, , p. 41–54. (PMID17400246, DOI10.1016/j.jmb.2007.03.006., lire en ligne)
elsevier.com
linkinghub.elsevier.com
(en) Meyer PR, Rutvisuttinunt W, Matsuura SE, So AG, Scott WA, « Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet », J Mol Biol., vol. 369, no 1, , p. 41–54. (PMID17400246, DOI10.1016/j.jmb.2007.03.006., lire en ligne)
nih.gov
ncbi.nlm.nih.gov
(en) Canestri A, Ghosn J, Wirden M. et al., « Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistance », Antivir. Ther. (Lond.), vol. 11, no 5, , p. 561–6. (PMID16964823)
(en) Mathiesen S, Dam E, Roge B. et al., « Long-term foscarnet therapy remodels thymidine analogue mutations and alters resistance to zidovudine and lamivudine in HIV-1 », 335–43., Antivir. Ther. (Lond.), vol. 12, no 3, (PMID17591023)
(en) Meyer PR, Rutvisuttinunt W, Matsuura SE, So AG, Scott WA, « Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet », J Mol Biol., vol. 369, no 1, , p. 41–54. (PMID17400246, DOI10.1016/j.jmb.2007.03.006., lire en ligne)
Bonnafous P, Naesens L, Petrella S, et al (2007). "Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet". Antivir. Ther. (Lond.) 12 (6): 877–88. PMID17926642.
